Ultomiris Astrazeneca News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ultomiris Astrazeneca. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ultomiris Astrazeneca Today - Breaking & Trending Today

Argenx's Vyvgart Offers a Substantial Advance Over Other Treatments for Generalized Myasthenia Gravis, Spherix Survey Suggests

Published: February 14, 2022

/PRNewswire/ -- At the end of last year, argenx's Vyvgart (efgartigimod alfa-fcab) was approved by the FDA for the treatment of generalized myasthenia gravis...

Source: prnewswire.com

Related Topics:

Roche GenentechRoche Genentech OcrevusVyvgart ArgenxUltomiris AstrazenecaAstrazeneca UltomirisOur ServicesLaunch DynamixGeneralized Myasthenia GravisHorizon TherapeuticsMarket DynamixGlobal InsightsSpherix Global Insights